News

Joint Committee for Vaccination and Immunisation (JCVI) announcement on  a third COVID-19 vaccine dose for renal patients on immunosuppression

Joint Committee for Vaccination and Immunisation (JCVI) announcement on a third COVID-19 vaccine dose for renal patients on immunosuppression

Date: 24 September 2021 | By: paul

Joint Committee for Vaccination and Immunisation (JCVI) announcement on a third COVID-19 vaccine dose for renal patients on immunosuppression


The JCVI has now advised a third COVID-19 vaccine dose (described as a third primary dose) for patients who are significantly immunocompromised and therefore may not have had a full immune response to the standard two vaccine course. They have also stated that the specialist involved should advise on whether the patient fulfils the eligibility criteria and on the timing of any third primary dose.

DOWNLOAD HERE


Loading...